Ony Inc

Randall Burkard is the CEO of ONY Biotech. To contact Randall Burkard email at [email protected] or [email protected].

ONY Biotech's primary product is Infasurf® (calfactant), which is specifically designed to prevent and treat respiratory distress syndrome (RDS) in premature infants. RDS is a serious condition that affects newborns, particularly those born before 34 weeks of gestation, and Infasurf® works by replacing the missing surfactant in the lungs, helping to improve lung function and oxygenation.

ONY Biotech primarily serves the neonatal healthcare industry, focusing on hospitals and healthcare providers that care for premature infants. Their products are used in neonatal intensive care units (NICUs) where specialized care is required for vulnerable newborns suffering from conditions like respiratory distress syndrome.

ONY Biotech adheres to strict regulatory standards set by the FDA and other health authorities to ensure the quality and safety of its products. This includes rigorous testing during the development phase, as well as ongoing quality control measures throughout the manufacturing process. The company is committed to maintaining high standards to protect the health of premature infants.

ONY Biotech focuses on innovation by investing in research and development to enhance the efficacy of its products. The company collaborates with leading medical professionals and institutions to gather insights and feedback, which helps in refining existing products and developing new solutions tailored to the needs of premature infants and their caregivers.

Yes, ONY Biotech provides various resources and training opportunities for healthcare providers. This includes educational materials, product demonstrations, and support from clinical specialists to ensure that medical staff are well-informed about the proper use of Infasurf® and other products. Providers can contact ONY Biotech directly for more information on available resources.

As a family-focused company, ONY Biotech is dedicated to supporting not only the health of premature infants but also the families involved in their care. The company recognizes the emotional and physical challenges that families face during this time and strives to provide products and resources that enhance the overall care experience for both infants and their families.